ArticleG3 (Bethesda, Md.)2026
Genetic analyses enabled by the fourth chromosome resource project reveal unexpected mutant phenotypes and suggest new disease models.
Article in G3 (Bethesda, Md.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
To date, the Fourth Chromosome Resource Project (FCRP) has deposited over 850 stocks for the genetic analysis of its 79 protein-coding genes. Here, we employ those stocks to reveal unexpected phenotypes for multiple exemplar genes. Expression studies of the transcript and protein provide clues to an adult function for maverick, a gene that, despite prior efforts, has remained inscrutable. Loss-of-function studies reveal an adult brain phenotype for the well-studied signal transducer legless and the first phenotype for datilographo, a gene with no prior mutations. Marked clones with a new eyeless null allele in the larval brain elicited the first heterochronic phenotype in flies. Mutant clones of myoglianin encompassing the entire adult glial blood-brain barrier elicited overgrowth of the underlying optic lobes. Complete clones of one glial layer within the two-layer barrier were obtained for multiple genes and provide an opportunity to interrogate barrier crossing mechanisms for neurological therapeutics. In overexpression studies, rough eye phenotypes were generated by two human genes known to cause autosomal dominant neurological diseases. How YY1 and GRM1 haploinsufficiency leads to inherited cognitive impairment and spinocerebellar ataxia visible from birth is currently unknown. Fly eye phenotypes provide a tractable disease model for understanding their mechanism of action. Taken together, the ease with which mutant phenotypes were revealed suggests that a considerable amount of interesting biology remains to be uncovered on the fourth chromosome.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.